| Biomarker ID | 1085 |
| PMID | 23538390 |
| Year | 2013 |
| Biomarker | miR-183 |
| Biomarker Basis | Expression Based |
| Biomolecule | miRNA |
| Source | Cell Lines |
| Subjects | Humans |
| Regulation | Upregulated in PC Cells |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- Gene expression (Transcription); Generic Transcription Pathway; RNA Polymerase II Transcription; synapse; glutamatergic synapse |
| Experiment | Prostate Cancer Cell Lines Vs Normal Prostate Cell Lines |
| Type of Biomarker | Diagnostic |
| Cohort | RWPE-1 was chosen to measure normal prostate epithelial cell lines, and PC-3, DU-145 and LNCaP were used to measure Prostate Cancer Cell Lines |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.05 |
| Method Used | real-time PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on Human Patient Cohort |
| Technical Name | miR-183 |